Portfolio comparison
University of Pennsylvania Penn vs Novartis AG
Side-by-side portfolio analysis — patents indexed, year ranges, and activity timeline.
Company A
University of Pennsylvania Penn
Patents indexed
4
Year range
2012 – 2024
Most recent
2024
biotechpharmaceuticalgene_editingoncologytelecommunications
Top Patents4 enriched
US 8278036· 2012
How Modified RNA Tricks Cells Into Making Proteins Without Triggering Attacks
US 9481728· 2016
How Genetically Modified T-Cells Fight CD19 Cancers
US 9328156· 2016
How Genetically Modified T-Cells Attack Cancer
Activity by Decade
2010s3
2020s1
Top Patents2 enriched
US 10472419· 2019
How Novartis Engineered Antibodies to Block the TIM-3 Immune Checkpoint
US 7740842· 2010
How to Keep High-Concentration Antibody Medicines Stable in Liquid Form
Activity by Decade
2010s2
How to use
Bookmark a comparison URL to save it. Format: /compare/companies?a=[slug]&b=[slug]. Also see patent-level comparison.